Abiopharma

Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial

Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties

Illumina, Inc. - Illumina secures CMS reimbursement forTruSight™ Oncology Comprehensive, expanding access to precision oncology

Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia

Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes

RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center

Curaleaf Announces Strong Preliminary Unaudited Fourth Quarter 2025 Results